Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AIDS-Related Opportunistic Infections
- Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
- Cryptococcal Antigen Screening Plus Sertraline
- Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
- Intralesional Bevacizumab for Treating AIDS-associated KaposiĀ“s Sarcoma of the Larynx, Pharynx and Oral Cavity
- Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
- Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
- When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
- Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
- Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
- A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
- A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
- A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
- Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
- Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma